Aralez Pharmaceuticals Inc (ARZ) Trading Down 5.4%

Shares of Aralez Pharmaceuticals Inc (TSE:ARZ) traded down 5.4% during mid-day trading on Tuesday . The stock traded as low as C$2.68 and last traded at C$2.78. 20,503 shares were traded during trading, a decline of 68% from the average session volume of 63,640 shares. The stock had previously closed at C$2.94.

The firm’s market capitalization is $189.85 million. The stock’s 50 day moving average is $2.28 and its 200-day moving average is $2.28.

TRADEMARK VIOLATION WARNING: This news story was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://ledgergazette.com/2017/10/10/aralez-pharmaceuticals-inc-arz-trading-down-5-4.html.

Aralez Pharmaceuticals Company Profile

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Receive News & Ratings for Aralez Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply